HiFiBiO SAS - Company Review
HiFiBiO SAS - Company ReviewSummary
HiFiBiO SAS (HiFiBiO) is a provider of integrated discovery platform. The company’s platform creates unparalleled opportunities for discovering novel and differentiated therapeutic antibodies. It offers development of micro-fluidics, functional assays, next-generation sequencing and bioinformatics that supports its broad, proprietary portfolio of technologies. HiFiBiO’s product is used in pharmaceutical companies through multiple antibody discovery collaborations. The company provides research and development collaborations; and licensing arrangements with pharmaceutical, biotechnology companies and government agencies. It partners with Pfizer for the development of next generation microfluidic platform for antibody discovery. The company operates in France and the US. HiFiBiO is headquartered in Paris, France.
This comprehensive company report of HiFiBiO SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.